CooperVision, a division of CooperCompanies, announced the appointment of Muru Annamalai as president, Asia-Pacific, effective June 1. Annamalai brings more than 2 decades of global leadership experience across the pharmaceutical and health care sectors, with extensive expertise leading commercial organizations and driving growth across Asia-Pacific, Latin America, and other global markets, the company said.  He has held a series of senior leadership roles with AbbVie and Abbott, and most recently, he served as a vice president with TCA Venture Group, where he was active in the venture and investment community, supporting innovation and growth initiatives in health care.

Annamalai replaces Richard Cheshire, who held the position since November 2025, and Cheshire will support Annamalai's onboarding through August 2026.